Skip to main content

Newcastle Disease (ND)

Overview

Newcastle disease (ND) is a highly contagious viral disease affecting a wide range of domestic and wild bird species. It is caused by virulent strains of Avian orthoavulavirus 1 (AOAV-1), formerly known as avian paramyxovirus type 1 (APMV-1). It is one of the most important diseases in the global poultry industry due to its substantial economic impact, resulting from high mortality, reduced meat and egg production, and trade restrictions imposed during outbreaks. The disease presents with a wide spectrum of clinical manifestations, ranging from mild respiratory infections to severe systemic disease associated with high mortality (WOAH, 2021).

Etiology and Virus Characteristics

Newcastle disease virus belongs to the family Paramyxoviridae, genus Orthoavulavirus, and corresponds to Avian orthoavulavirus 1 (AOAV-1). It is an enveloped virus with a non-segmented, single-stranded negative-sense RNA genome of approximately 15.2 kb (WOAH, 2021).

The viral genome encodes six major structural proteins:

The fusion (F) protein is one of the principal determinants of viral virulence.

Classification of NDV Strains According to Virulence

PathotypeCharacteristics
LentogenicLow virulence; primarily causes mild respiratory disease
MesogenicIntermediate virulence
Neurotropic velogenicSevere disease with predominant neurological signs
Viscerotropic velogenicHighly virulent form characterized by digestive lesions and high mortality

Circulating strains are also classified into multiple genotypes. Genotype VII is currently associated with most major outbreaks reported worldwide (Hy-Line, 2025).

Pathogenesis and Immunity

Following entry through the respiratory or digestive tract, the virus replicates in the respiratory and intestinal epithelium before spreading via the bloodstream to various organs.

Disease severity depends on several factors, including:

FactorInfluence on Disease
Young birdsIncreased susceptibility
Maternal antibodiesTemporary protection
VaccinationReduces clinical signs and mortality
ImmunosuppressionExacerbates infection

Maternal antibodies provide early protection but may interfere with certain vaccination programs. Protective immunity relies on both humoral and cell-mediated immune responses.

Transmission

Newcastle disease is transmitted primarily through horizontal transmission.

Infected birds shed the virus in:

Transmission occurs through direct contact between birds or indirectly via:

The virus can survive for several weeks in the environment, particularly at low temperatures and in the presence of organic matter.

Clinical Signs and Lesions

The incubation period generally ranges from 2 to 15 days.

Clinical manifestations vary according to the viral pathotype.

Clinical SignsTypical Lesions
DepressionTracheal congestion
Dyspnea and respiratory ralesIntestinal hemorrhages
Coughing and sneezingHemorrhagic lesions of the proventriculus
Greenish diarrheaNecrotic enteritis
TorticollisPulmonary congestion
Paralysis of wings and legsPeriorbital edema
Drop in egg productionOvarian atrophy
High mortalityMultifocal hemorrhages

In viscerotropic forms, characteristic hemorrhages are observed in the cecal tonsils and proventriculus.

Mortality may reach 100% in susceptible flocks infected with highly virulent strains.

Diagnosis

Diagnosis is based on the combination of:

Differential Diagnosis

Newcastle disease should be differentiated from:

Definitive diagnosis relies on:

Prevention and Control

Effective prevention of Newcastle disease relies on a combination of strict biosecurity measures and appropriate vaccination programs.

Key biosecurity measures include:

Vaccination

Vaccination remains the cornerstone of Newcastle disease prevention.

Vaccine TypeExamples
Live attenuated vaccinesB1, Hitchner B1, LaSota
Inactivated vaccinesOil-emulsion layer vaccines
Recombinant vaccinesHVT- or FPV-vectored vaccines
Genotype VII homologous vaccinesRecommended in areas with high infection pressure

Vaccination programs should be adapted according to maternal antibody levels, production type, and the local epidemiological situation.

MCI Solutions

MCI Santé Animale offers a vaccine solution for the prevention of Newcastle disease in poultry.

MCI's Newcastle disease vaccine portfolio includes: